MPN are clonal myeloid neoplasms including essential thrombocytosis (ET), polycythemia vera (PV) and myelofibrosis (MF) sharing common driver mutations in the JAK2, CALR or MPL genes but with a notable variability in the clinical presentations and outcomes [19]. This evidence concerns the gene JAK2 and acquired polycythemia vera.